Search

Your search keyword '"Joyner, M"' showing total 571 results
Start Over Author "Joyner, M"
571 results on '"Joyner, M"'

1. Reply to Williams et al. : Fair and Safe Eligibility Criteria for Women's Sport

Author

Tucker, R., Hilton, E., McGawley, Kerry, Pollock, N., Millet, G., Sandbakk, Ø., Howatson, G., Brown, G., Carlson, L., Chen, M., Heron, N., Kirk, C., Murphy, M., Pringle, J., Richardson, A., Santos-Concejero, J., Christiansen, A., Jones, C., Alonso, J. -M, Robinson, R., Jones, N., Wilson, M., Parker, M., Chintoh, A., Hunter, S., Senefeld, J., O'Connor, M., Joyner, M., Carneiro, E., Devine, C., Pike, J., Lundberg, T., Tucker, R., Hilton, E., McGawley, Kerry, Pollock, N., Millet, G., Sandbakk, Ø., Howatson, G., Brown, G., Carlson, L., Chen, M., Heron, N., Kirk, C., Murphy, M., Pringle, J., Richardson, A., Santos-Concejero, J., Christiansen, A., Jones, C., Alonso, J. -M, Robinson, R., Jones, N., Wilson, M., Parker, M., Chintoh, A., Hunter, S., Senefeld, J., O'Connor, M., Joyner, M., Carneiro, E., Devine, C., Pike, J., and Lundberg, T.

Published
2024
Full Text
View/download PDF

3. Understanding the Gender and Ethnicity Attainment Gap in UK Higher Education

Author

Cotton, D. R. E., Joyner, M., George, R., and Cotton, P. A.

Abstract

In recent years, the success rates of different groups of students in higher education have come under considerable scrutiny, with gender and ethnicity identified as key attributes predicting differential achievement of "good degrees". A review of previous studies highlights the need for research which looks beyond "the deficit model" to explain the attainment gap. This research used a mixed-methods approach to explore the academic and social experiences of students, as well as lecturers' views on student achievement, in one UK University. Findings suggest that there are significant differences in motivation and confidence speaking English for different ethnic groups in this study, and a divergence in attendance and study time by gender--both of which may go some way to helping understand the gaps in attainment. In addition, male and BME students tended to overestimate their likelihood of achieving a good degree outcome, compared to other groups.

Published
2016
Full Text
View/download PDF

4. PD-0414 ERAS pathway for gynecologic cancer patients receiving brachytherapy: A prospective clinical trial

Author

Andring, L., primary, Corrigan, K., additional, Bailard, N., additional, Rooney, M., additional, Domingo, M., additional, Varkey, J., additional, Foster-Mills, T., additional, Fellman, B., additional, Lin, L., additional, Jhingran, A., additional, Colbert, L., additional, Eifel, P., additional, Klopp, A., additional, and Joyner, M., additional

Published
2023
Full Text
View/download PDF

6. A

Author

Boehm, Ulrich, Mays, Lawrence, Yost, William A., Stoecker, Ralf, Windhorst, Uwe., Lalley, Peter M., Bamert, Laura, Mast, Fred W., Chapman, Christine Elaine, Land, Michael F., Gundelfinger, Eckart D., Altrock, Wilko, Fejtová, Anna, Colicos, Michael A., Feuer, Arie, Goodwin, Graham C., Ortega-Pérez, Inmaculada, Santer, Robert M., Verrillo, Ronald T., Van Dongen, Hans P. A., Belenky, Gregory, Wislet-Gendebien, S., Tandon, A., Shen, Yiru, Sung, Ying Ying, Wah Soong, Tuck, Volk, Talila, Klämbt, Christian, Summers, William K., Korneva, Helen A., Calhoun-Haney, Rose M., Zola, Stuart M., McDonald, Alexander J., Vanderah, Todd W., Epstein, Marcelo, Alheid, George F., McCrimmon, Donald R., Brunjes, Peter C., Illig, Kurt R., Woollacott, Marjorie, Benke, Tim A., Darlington, Cynthia L., Diamond, Betty, Volpe, Bruce T., Horii, Arata, Miller, Robert, Fellow, Honorary, Hinton, Tina, Johnston, Graham A. R., Busse, Ralf, Flash, Tamar, Maoz, Uri, Polyakov, Felix, Beaulé, Christian, Herzog, Walter, Amirikian, Bagrat, Davidson, Steve, Giesler, Glenn J., Jr, Manabe, Toshiya, Hirahara, Makoto, Klaver, Peter, Schreiner, Christoph E., Winer, Jeffery A., Kraus, Nina, Nicol, Trent, Metzner, Walter, Siegel, Jonathan, Seidl, Armin H., Rubel, Edwin W., Yamaguchi, Kazuhiko, Pluchino, Stefano, Zanotti, Lucia, Martino, Gianvito, Schwartz, Michal, Yoles, Eti, Passatore, Magda, Roatta, Silvestro, Joyner, M. J., Mano, Tadaaki, McLachlan, Elspeth, Budgell, Brian, Furness, John B., Jänig, Wilfrid, Low, Phillip A., Clinic, Mayo, Wood, Jackie D., Litvin, Yoav, Blanchard, D. Caroline, Arakawa, Hiroyuki, Blanchard, Robert J., Gallo, Milagros, Theunissen, Frédéric E., Zochodne, D. W., Hirata, Tatsumi, Yamamoto, Nobuhiko, Spencer, Gaynor E., Farrar, Nathan R., Carlone, Robert, Tam, Siu Lin, Gordon, Tessa, Binder, Marc D., editor, Hirokawa, Nobutaka, editor, and Windhorst, Uwe, editor

Published
2009
Full Text
View/download PDF

50. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19.

Author

Joyner, M. J., Carter, R. E., Senefeld, J. W., Klassen, S. A., Mills, J. R., Johnson, P. W., Theel, E. S., Wiggins, C. C., Bruno, K. A., Klompas, A. M., Lesser, E. R., Kunze, K. L., Sexton, M. A., Soto, J. C. Diaz, Baker, S. E., Shepherd, J. R. A., van Helmond, N., Verdun, N. C., Marks, P., and van Buskirk, C. M.

Subjects
*CONVALESCENT plasma, *COVID-19, *IMMUNOGLOBULIN G, *IMMUNOGLOBULINS
Abstract

Background: Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19) under the presumption that such plasma contains potentially therapeutic antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that can be passively transferred to the plasma recipient. Whether convalescent plasma with high antibody levels rather than low antibody levels is associated with a lower risk of death is unknown.Methods: In a retrospective study based on a U.S. national registry, we determined the anti-SARS-CoV-2 IgG antibody levels in convalescent plasma used to treat hospitalized adults with Covid-19. The primary outcome was death within 30 days after plasma transfusion. Patients who were enrolled through July 4, 2020, and for whom data on anti-SARS-CoV-2 antibody levels in plasma transfusions and on 30-day mortality were available were included in the analysis.Results: Of the 3082 patients included in this analysis, death within 30 days after plasma transfusion occurred in 115 of 515 patients (22.3%) in the high-titer group, 549 of 2006 patients (27.4%) in the medium-titer group, and 166 of 561 patients (29.6%) in the low-titer group. The association of anti-SARS-CoV-2 antibody levels with the risk of death from Covid-19 was moderated by mechanical ventilation status. A lower risk of death within 30 days in the high-titer group than in the low-titer group was observed among patients who had not received mechanical ventilation before transfusion (relative risk, 0.66; 95% confidence interval [CI], 0.48 to 0.91), and no effect on the risk of death was observed among patients who had received mechanical ventilation (relative risk, 1.02; 95% CI, 0.78 to 1.32).Conclusions: Among patients hospitalized with Covid-19 who were not receiving mechanical ventilation, transfusion of plasma with higher anti-SARS-CoV-2 IgG antibody levels was associated with a lower risk of death than transfusion of plasma with lower antibody levels. (Funded by the Department of Health and Human Services and others; ClinicalTrials.gov number, NCT04338360.). [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results